Product Information

CEPHALEXIN 250 MG/5 ML SUSP is a generic product labeled by Teva Pharmaceuticals USA Inc., priced at $0.0683 per ML under NDC 00093417773. Its NADAC has been published 677 times since Nov 28, 2013.

FDA first approved this application on Feb 13, 1987. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

CEPHALEXIN 250 MG/5 ML SUSP

Cephalexin
$0.0683per ML

Strength

250 mg/5mL

NDC

00093417773

Classification

Generic

Dosage Form

POWDER, FOR SUSPENSION

Route

ORAL

Effective Date

10/21/2026

Active Ingredients

CEPHALEXIN

Approval Type

Generic (ANDA)

FDA Application

ANDA062703

FDA Approved

2/13/1987

TE Code

AB

On Market Since

9/30/1990

Pharmacological Classes

Price Statistics

The NADAC for CEPHALEXIN 250 MG/5 ML SUSP has been published 677 times since Nov 28, 2013, and over the history we have for it it has risen 30.8%. The table below summarizes its recorded NADAC range and movement.

Current price$0.0683 per ML
All-time high$0.1931 (Aug 13, 2014)
All-time low$0.0519 (Dec 18, 2013)
52-week high$0.0790
52-week low$0.0683
Median price$0.1080
Average price$0.1147
Largest weekly change+221.4% (Jun 18, 2014)
Weeks tracked677
Tracking sinceNov 28, 2013

Price History

1W

0.0%

1M

-3.8%

3M

-10.4%

6M

-8.3%

1Y

-12.0%

3Y

-13.3%

5Y

-33.1%

All

+30.8%

Generic Alternatives

The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 29% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of CEPHALEXIN 250 MG/5 ML SUSP?

The current National Average Drug Acquisition Cost (NADAC) for CEPHALEXIN 250 MG/5 ML SUSP, manufactured by Teva Pharmaceuticals USA Inc., is $0.0683 per ML (NDC 00093417773), effective Nov 11, 2026.

How has the price of CEPHALEXIN 250 MG/5 ML SUSP changed over time?

Over the history we have for it, the NADAC for CEPHALEXIN 250 MG/5 ML SUSP has risen 30.8%. It has been tracked across 677 weekly CMS publications since Nov 28, 2013.

What are the highest and lowest recorded NADAC prices for CEPHALEXIN 250 MG/5 ML SUSP?

Since Nov 28, 2013, the NADAC for CEPHALEXIN 250 MG/5 ML SUSP has ranged from a low of $0.0519 (Dec 18, 2013) to a high of $0.1931 (Aug 13, 2014), with a median of $0.1080 per ML.

Are there cheaper alternatives to CEPHALEXIN 250 MG/5 ML SUSP?

Yes. 2 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, CEPHALEXIN 250 MG/5 ML SUSP, is $0.0488 per ML — about 29% below CEPHALEXIN 250 MG/5 ML SUSP.

Who manufactures CEPHALEXIN 250 MG/5 ML SUSP?

CEPHALEXIN 250 MG/5 ML SUSP (NDC 00093417773) is labeled by Teva Pharmaceuticals USA Inc., and CMS classifies it as a generic product.